-
1741
Prospective Longitudinal Characterization of the Relationship between Diabetes and Cardiac Structural and Functional Changes
Published 2022-01-01“…Objectives. In a cohort of type 2 diabetic (T2D) patients who underwent baseline cardiac magnetic resonance (CMR) and biomarker testing, during a median follow-up of 6 years, we aimed to determine longitudinal changes in the phenotypic expression of heart disease in diabetes, report clinical outcomes, and compare baseline clinical characteristics and CMR findings of patients who experienced major adverse cardiovascular events (MACE) to those remaining MACE free. …”
Get full text
Article -
1742
The Clinical Pharmacokinetics and Pharmacodynamics of Glimepiride—A Systematic Review and Meta-Analysis
Published 2025-01-01“…<b>Background/Objectives:</b> Glimepiride (GLM), a commonly used sulphonylurea drug for the management of type 2 diabetes mellitus (T2DM), has been the subject of numerous studies exploring its kinetic behaviors. …”
Get full text
Article -
1743
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study
Published 2021-01-01“…However, whether ranolazine may improve short-term glycemic variability (GV), strictly related to the prognosis of patients with type 2 diabetes (T2D), is unknown. Thus, we aimed to explore the effects of adding ranolazine to standard anti-ischemic and glucose-lowering therapy on long- and short-term GV as well as on endothelial function and oxidative stress in patients with T2D and CCS. …”
Get full text
Article -
1744
miR-210 in Exosomes Derived from Macrophages under High Glucose Promotes Mouse Diabetic Obesity Pathogenesis by Suppressing NDUFA4 Expression
Published 2020-01-01“…Objective. Type 2 diabetes mellitus (T2DM) is featured by insulin resistance and lipid metabolism dysregulation. …”
Get full text
Article -
1745
Impact of dapagliflozin on metabolic phenotype, hormone levels, and fertility in female mice after prolonged high-fat diet
Published 2025-01-01“…The sodium-glucose cotransporter 2 inhibitors (SGLT2i) have emerged as a treatment for type 2 diabetic patients, regulating adipose tissue metabolism, hypothalamic inflammation, and ovulation in women with polycystic ovary syndrome (PCOS). …”
Get full text
Article -
1746
Exploring the path to optimal diabetes care by unravelling the contextual factors affecting access, utilisation, and quality of primary health care in West Africa: A scoping review...
Published 2024-01-01“…Over 90% of cases are Type 2 diabetes (IDF, World Bank). As diabetes is ambulatory care sensitive, good primary care is crucial to reduce complications and mortality. …”
Get full text
Article -
1747
Evaluation of macular retinal oximetry across different levels of diabetic retinopathy: a cross sectional study
Published 2025-01-01“…Abstract Background This study evaluates retinal oxygen saturation and vessel density within the macula and correlates these measures in controls and subjects with type 2 diabetes (DM) with (DMR) and without (DMnR) retinopathy. …”
Get full text
Article -
1748
Prevalence of diabetes-related sarcopenia and its defining components within primary care: A cross-sectional study
Published 2025-04-01“…This study aimed to assess the prevalence of sarcopenia and at-risk morphofunctional (MF) phenotypes and to identify the factors associated in patients with type 2 diabetes (T2D), including non-elderly adults, in primary care settings Methods: This cross-sectional study included 261 individuals managed in primary care units in Mexico City, between July 2022 and May 2024. …”
Get full text
Article -
1749
Mutation yellow in agouti loci prevents age-related increase of skeletal muscle genes regulating free fatty acids oxidation
Published 2018-04-01“…The lethal yellow mutation in agouti loci (Ay mutation) reduces the activity of melanocortin (MC) receptors and causes hyperphagia, obesity and type two diabetes mellitus in aging mice (Ay mice). It is unknown if changes in distinct elements of the metabolic system such as white adipose tissue (WAT) and brown adipose tissue (BAT), and skeletal muscle will manifest before the development of obesity. …”
Get full text
Article -
1750
Elevated and Correlated Expressions of miR-24, miR-30d, miR-146a, and SFRP-4 in Human Abdominal Adipose Tissue Play a Role in Adiposity and Insulin Resistance
Published 2018-01-01“…Abdominal adipose tissue (AbdAT) levels of thirteen microRNAs (miRNAs), SFRP4, and VEGF in lean nondiabetic subjects (n=7), subjects with obesity (n=5), and subjects with obesity and type 2 diabetes (T2DM) (n=5) were measured by qPCR. Insulin sensitivity was measured by the euglycemic-hyperinsulinemic clamp. …”
Get full text
Article -
1751
Contributions of Fasting and Postprandial Glucose Concentrations to Haemoglobin A1c in Drug-Naïve Mal-Glucose Metabolism in Chinese Population Using Continuous Glucose Monitoring S...
Published 2019-01-01“…To clarify the contributions of fasting glucose (FG) and postprandial glucose (PG) to HbA1c in drug-naïve patients with type 2 diabetes (T2D) and impaired glucose tolerate (IGT)/impaired fasting glucose (IFG). …”
Get full text
Article -
1752
Multi-omics mechanical analysis of gut microbiota, carboxylic acids, and cardiac gene expression interaction triggering diabetic cardiomyopathy
Published 2025-01-01“…Also, according to the Pearson correlation analysis, a significant positive correlation was found between CAs and PPAR signaling pathway-related DEGs, and a negative correlation was found between CAs and the abundance of the above-mentioned species. To sum up, type 2 diabetes mellitus (T2DM) can upregulate the expression of partial cardiac genes through the levels of serum short-chain CAs affected by gut microbiota, thus playing a role in the occurrence and development of diabetic cardiomyopathy (DCM).IMPORTANCEOur research results clearly link the changes in heart genes of T2DM and normal mice with changes in serum metabolites and gut microbiota, indicating that some genes in biological processes are closely related to the reduction of protective microbiota in the gut microbiota. …”
Get full text
Article -
1753
Serum adropin levels as a potential biomarker for predicting diabetic kidney disease progression
Published 2025-02-01“…BackgroundTo investigate the value of serum adropin in predicting chronic kidney disease (CKD) progression in subjects with type 2 diabetes (T2D).Materials and methodsSerum adropin levels were measured in normal control and T2D patients with various stage of CKD. …”
Get full text
Article -
1754
The Role of Quercetin and Exercise in Modulating Apoptosis and Cardiomyopathy via PI3K/AKT/FOXO3 Pathways in Diabetic Obese Rats
Published 2024-09-01“…The rats were fed a high-fat diet (HFD) for 8 weeks and a low dose of streptozotocin (STZ)was administered to create a model of type 2 diabetes mellitus (T2DM). Eight weeks of HIIT and MICT with or withoutquercetin treatment were performed. …”
Get full text
Article -
1755
The Determinants of Adolescent Glycolipid Metabolism Disorder: A Cohort Study
Published 2022-01-01“…The increased prevalence of glycolipid metabolism disorders (GLMD) in childhood and adolescents has a well-established association with adult type 2 diabetes and cardiovascular diseases; therefore, determinants of GLMD need to be evaluated during this period. …”
Get full text
Article -
1756
One-Year Clinical Outcome in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
Published 2022-01-01“…Independent predictors for all-cause mortality in patients with NVAF were age>75 years, heart failure, major bleeding event, type 2 diabetes mellitus, study enrollment as an in-patient, and coronary heart disease. …”
Get full text
Article -
1757
High Glucose with Insulin Induces Cell Cycle Progression and Activation of Oncogenic Signaling of Bladder Epithelial Cells Cotreated with Metformin and Pioglitazone
Published 2019-01-01“…This study investigated molecular mechanism underlying effects of metformin and pioglitazone in bladder epithelial carcinogenesis in type 2 diabetes. The cells derived from human bladder epithelial cells (HBlEpCs) were treated with metformin or pioglitazone with high glucose and insulin. …”
Get full text
Article -
1758
Digital intervention promoting physical activity among obese people (DIPPAO) randomised controlled trial: study protocol
Published 2022-06-01“…Introduction Physical inactivity and excessive sedentary behaviours are major preventable causes in both the development and the treatment of obesity and type 2 diabetes mellitus (T2DM). Nevertheless, current programmes struggle to engage and sustain physical activity (PA) of patients over long periods of time. …”
Get full text
Article -
1759
A Cloud-Based Optimized Ensemble Model for Risk Prediction of Diabetic Progression—An Azure Machine Learning Perspective
Published 2025-01-01“…This study introduces an optimized Light Gradient-Boosting Machine (Light GBM) and K-Nearest Neighbour (KNN) based ensemble algorithm for predicting diabetic progression of Type 2 Diabetes, classifying it as high or low risk, using patient health parameters and serum measurements. …”
Get full text
Article -
1760
Digital health technologies and innovation patterns in diabetes ecosystems
Published 2025-02-01“…Background The global rise in type-2 diabetes (T2D) has prompted the development of new digital technologies for diabetes management. …”
Get full text
Article